
Corporate Governance23 Oct 2026, 02:43 pm
Sahajanand Medical Technologies Authorizes KMPs for Disclosure
AI Summary
Sahajanand Medical Technologies Ltd has authorized its Key Managerial Personnel (KMPs) to determine the materiality of events and make disclosures to stock exchanges as per SEBI (LODR) Regulations, 2015. The authorized KMPs include Mr. Bhargav Dhirajlal Kotadia (Managing Director & CEO), Mr. Amit Kumar Khandelia (Chief Financial Officer), and Ms. Deepshikha Singhal (Company Secretary & Compliance Officer). This move streamlines the disclosure process and ensures compliance with regulatory requirements. The details are also available on the company's website.
Key Highlights
- KMPs authorized for disclosure under SEBI LODR.
- MD & CEO, CFO, and CS are designated for materiality.
- Ensures timely and compliant regulatory disclosures.
- Details available on the company website.
Price Impact
More from SMT